Although they’re the stuff of science, statistics too often lack the power to move us. After all, they’re just numbers. So when companies like Dendreon Corp. and Seattle Genetics Inc. price their cancer treatments at nearly $100,000 or more, we…
Tag Archives: Seattle Genetics Inc
First-Half Biotech Fundraising: What You Need to Know
July 11, 2011 – 9:21 am
We just finished running the numbers for biotech fundraising in the first half of 2011, and . . . drum roll please . . . the numbers are good! Well, they’re good if you’re a publicly traded, pre-commercial biotech, anyway.
Join the Conversation